GlassScriptPhysician profile
Eugene D Zoog
NPI 1124021217
$8,715.52
in general payments reported to CMS, 2019-2025
21 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2020: $213 · 2021: $1,478 · 2022: $1,355 · 2023: $1,342 · 2024: $2,048 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,312 · Travel and Lodging: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,312.24 |
| Travel and Lodging | $546.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,654.28 | 2019-2024 | Prophecy, Citrefix, Hoffmann |
| Convatec INC. | $1,188.04 | 2024-2025 | |
| Treace Medical Concepts, INC. | $897.41 | 2021 | |
| Smith+Nephew, INC. | $592.55 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix Mesh |
| Cdc Medical LLC | $361.00 | 2019 | |
| Organogenesis INC. | $224.26 | 2022-2025 | Apligraf, Simplimax, Via Matrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $151.90 | 2022-2024 | Jublia |
| Sanara Medtech INC. | $146.16 | 2025 | Celleraterx |
| Rikco International, LLC | $88.00 | 2019 | |
| Cardiovascular Systems INC. | $77.96 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $61.53 | 2023 | Seglentis |
| Paragon 28, INC. | $56.00 | 2019-2020 | |
| Wright Medical Technology, INC. | $41.15 | 2019 | |
| Bioventus LLC | $40.75 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Biotissue Holdings INC. | $39.32 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.43 | 2025 | Krystexxa |
| Medtronic, INC. | $20.06 | 2023 | Intellis Adaptivestim |
| Averitas Pharma INC. | $19.88 | 2024 | Qutenza |
| Melinta Therapeutics, LLC | $14.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.59 | 2019 | |
| Orthofix Medical, INC. | $6.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Zoog listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.